Publication | Closed Access
Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer
144
Citations
22
References
2003
Year
In this phase II study, intravenous CI-1042 was administered safely to patients with advanced colorectal cancer. Toxicity was manageable, consisting primarily of flu-like symptoms. Stable disease was experienced by seven patients for 11 to 18 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1